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ABSTRACT

Walking is a simple, feasible, and effective exercise modality in which providers can instruct
patients as a component of type II diabetic treatment plans. Many patients are overwhelmed
when given instructions to exercise and therefore never begin. Lack of exercise contributes to
poor glycemic control and adverse outcomes. Also, gym memberships can be expensive resulting
in patients forgoing exercise altogether. The purpose of this DNP scholarly project was to
conduct research outcomes which may enlighten providers to prescribe exercise interventions by
providing evidence walking 45 minutes three times a week can improve glycemic control among
type II diabetic patients. Also, the DNP scholarly project sought to answer the following clinical
question: In type II diabetic patients, what is the effect of walking 45 minutes three times a week
on HgbA1c levels compared with no exercise within three months? A group of four type II
diabetics participated in walking 45 minutes three times a week for 12 weeks. The projected
outcome was lowered HgbA1c among participants walking three times a week. HgbA1c was
evaluated at the beginning of the project and at the end of the 12-week implementation period.
The project aimed to examine the efficacy of walking as an effective and feasible exercise
intervention for type II diabetic patients. The average HgbA1c among the group decreased from
8.4 to 7.475. Providers can prescribe walking prescriptions for type II diabetic patients to
increase glucose control and lesson the stress for patients related to initiating exercise.

Keywords: type II diabetics, exercise, walking, glucose control, glycosylated hemoglobin
(HgbA1c)
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SECTION ONE: INTRODUCTION
Type II diabetes is a chronic medical condition plaguing today’s health care arena
causing significant burden of overall health and wellbeing for many individuals. Sadly, type II
diabetes is the most frequent metabolic condition seen throughout the world (Buttaro et al.,
2021). Management for type II diabetes places large financial stress on healthcare systems,
patients, and families (Arovah et al., 2018). Increased incidences of type II diabetes can be
contributed to poor lifestyle choices and escalations in rates of obesity and sedentary lifestyles
(Caron et al., 2018). Researchers estimate by 2035, about 592 million patients worldwide will be
diagnosed with type II diabetes (Ruffino et al., 2017).
Many patients struggle with long term management of type II diabetes considering the
complexity of the disease, motivation, social determinates of health, lifestyle, and socioeconomic status. Lifestyle changes, specifically exercise, can significantly improve outcomes for
type II diabetic patients and prevent adverse outcomes (Caron et al., 2018). Walking is a feasible
exercise which can improve glucose control for type II diabetics. The purpose of the DNP
scholarly project was to provide evidence to aid providers in prescribing walking prescriptions
for type II diabetic patients to increase patient outcomes and prevent complications.
Background
The pathophysiology of type II diabetes includes insulin resistance, impaired insulin
secretion, and increased hepatic production of glucose (Buttaro et al., 2021). Metabolic
syndrome is strongly related to the development of type II diabetes and presents with abdominal
obesity, increased triglycerides, low high-density lipoproteins, hyperglycemia, and insulin
resistance (Buttaro et al., 2021). However, type II diabetes can be prevented through lifestyle
changes such as diet and exercise (Yates et al., 2017). Symptoms of type II diabetes can progress
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slowly, and some patients may be asymptomatic for long periods of time (Buttaro et al., 2021).
Common symptoms include blurred vision, polyuria, polyphagia, polydipsia, and fatigue
(Buttaro et al., 2021). Proper treatment of type II diabetes is essential to prevent devastating
complications.
Type II diabetes is the most common cause of cardiovascular disease (Buttaro et al.,
2021). Complications of uncontrolled type II diabetes includes retinopathy, nephropathy,
neuropathies, macrovascular complications, and microvascular complications (Buttaro et al.,
2021). Diabetic retinopathy may progress to total vision loss if untreated (Buttaro et al., 2021).
Patients who experience poor glucose control are at greater risk for blindness associated with
diabetic retinopathy (Buttaro et al., 2021). Sadly, evidence has revealed 80% of all type II
diabetics will develop diabetic retinopathy (Buttaro et al., 2021). Furthermore, uncontrolled type
II diabetes commonly results in diabetic neuropathy in 60 % of patients leading to end stage
renal disease (Buttaro et al., 2021). Nerve damage, coronary artery disease, cerebrovascular
accidents, and peripheral vascular disease are also common complications due to poor glucose
control (Buttaro et al., 2021).
The mainstay of treatments for type II diabetics are lifestyle changes, medications, and
close monitoring (Buttaro et al., 2021; Ruffino et al., 2017). Goals of treatment include
maintaining glucose within proper ranges, improving quality of life, and preventing
complications. Type II diabetes is a progressive disease which requires patient education and
frequent follow ups to prevent adverse patient outcomes. Treatment with medications alone is
not sufficient to successfully treat and manage type II diabetes.
Multiple studies have revealed that walking improves glucose control and overall health
among type II diabetics by improving the bodies glucoregulatory activity (Arovah et al., 2018;
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Chang et al., 2021; Karstoft et al., 2017; Moghetti et al., 2020; Regeer et al., 2020). Overall,
exercise such as walking lowers patients glycated hemoglobin (HgbA1c), reduces low density
lipoproteins, and lowers blood pressure which improves outcomes among type II diabetic
patients (Chang et al., 2021; Moghetti et al., 2020; Ruffino et al, 2017; Yates et al., 2017).
Walking lowers blood pressure by stimulating the release of vasodilators and increasing
baroreflex sensitivity (Change et al., 2021; Yates et al., 2017). Walking reduces low density
lipoproteins by implementing reverse transport of cholesterol (Chang et al., 2021). Walking
facilitates improvements in cardiometabolic health which decreases total and cardiovascular
mortality among type II diabetics (Arovah et al., 2018; Moghetti et al., 2020; Reynolds et al.,
2020).
Problem Statement
Exercise is an essential component of type II diabetic treatment plans to improve
outcomes and prevent complications (Caron et al., 2018; Moghetti et al., 2020; Ruffino et al.,
2017). However, many patients become overwhelmed when given instructions to exercise and
never begin. Lack of exercise contributes to poor glycemic control and adverse outcomes. Many
patients cannot afford expensive gym memberships and forgo exercise altogether. Walking is a
simple, feasible, and effective exercise modality which providers can instruct patients as a
component of type II diabetic treatment plans.
Purpose of the Project
The purpose of this DNP scholarly project was to aid providers in prescribing exercise
interventions by providing evidence that walking 45 minutes three times a week can improve
glycemic control among type II diabetic patients. Walking is a significant intervention for type II
diabetic patients to improve outcomes, improve quality of life and prevent complications (Regeer
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et al., 2020; Reynolds et al. 2020; Ruffino et al., 2017. A group of type II diabetics participated
in walking 45 minutes three times a week for 12 weeks. The projected outcome was lowered
HgbA1c among participants walking three times a week. HgbA1c was evaluated at the beginning
of the project and at the end of the 12 weeks. Participants were required to have a documented
HgbA1c within six months of the project start date. The DNP scholarly project aimed to examine
the efficacy of walking as an effective and feasible exercise intervention for type II diabetic
patients.
Clinical Question
In type II diabetic patients, what is the effect of walking 45 minutes three times a week
on HgbA1c levels compared with no exercise within three months?
SECTION TWO: LITERATURE REVIEW
Many type II diabetic patients do not fully understand what providers mean when given
instructions to exercise (Caron et al., 2018). Evidence has revealed a vast number of patients
struggle with implementing exercise interventions due to lack of knowledge, finances, and time
constraints (Caron et al., 2018; Chang et al., 2020; Moghetti et al., 2020; Regeer et al., 2020;
Reynolds et al., 2020; Ruffino et al, 2017; Yates et al., 2017). Exercise compliance is decreased
among patients who are just given general instructions to exercise (Caron et al., 2018). However,
walking is a safe, cost effective and efficient form of exercise for type II diabetics to improve
glycemic control, increase overall health, and prevent complications (Caron et al., 2018; Chang
et al., 2020; Moghetti et al., 2020; Regeer et al., 2020; Reynolds et al., 2020; Ruffino et al, 2017;
Yates et al., 2017).
Walking interventions can be completed anywhere and expensive gym memberships are
not required. Walking prescriptions can increase exercise compliance among type II diabetics
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(Reynolds et al., 2020). Exercise, such as walking, must be added to treatment plans as research
reveals walking accelerates adequate control of type II diabetes (Chang et al., 2020).
Search Strategy
A systematic search was conducted related to exercise and type II diabetes. Cochran
Database of Systematic Reviews, PubMed, CINAHL, and Ebsco were searched. The following
keywords were utilized in the search: exercise, walking, type II diabetes, and lifestyle
interventions. Parameters included peered reviewed studies published in English within the last
five years. Systematic reviews and randomized controlled trials were searched to present highest
levels of evidence. To narrow down the results, the terms walking, and type II diabetes were
implemented within the search. Fifteen articles were included in the literature review consisting
of three systematic reviews, five randomized controlled trials, four non-randomized controlled
trials, and three descriptive studies.
Critical Appraisal
Strengths of the literature review include high levels of evidence such as systematic
reviews of randomized controlled trials, randomized controlled trials, and non-randomized
controlled trials. Limitations of the studies selected include small sample sizes and not
accounting for comorbidities. A systematic review was conducted related to walking and type II
diabetes to provide clinical recommendations and found that walking improves glycemic control,
blood pressure, weight, and cardiopulmonary fitness (Moghetti et al., 2020). A randomized
controlled trial determined walking improves overall health and glycemic control (Arovah et al.,
2018). Research revealed even if type II diabetics walk at a slower pace, walking is still effective
for improving glycemic control based on a non-randomized trial (Caron et al., 2018). Multiple
studies revealed walking at slow, brisk, or interval pace lowers glycemic control and improves
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overall health among type II diabetics (Chang et al., 2021; Cigarroa et al., 2020; Karstoft et al.,
2017; Ruffino et al., 2017). Also, education related to walking among type II diabetic patients
increases exercise compliance (Yates et al., 2017). A table of evidence is provided (Appendix
A).
Synthesis
In review of evidence, walking interventions for type II diabetic patients can improve
glucose control, overall health, and prevent diabetic complications (Arovah et al., 2018; Chang et
al., 2021; Karstoft et al., 2017; Moghetti et al., 2020; Reeger et al., 2020). Medications alone are
not sufficient to manage type II diabetic patients. Lifestyle changes must be implemented to
insure best management of type II diabetes. Many patients become overwhelmed with strenuous
lifestyle changes which causes undo stress and anxiety. Furthermore, walking is a simple, low
cost, and effective exercise intervention to improve exercise compliance among type II diabetics
(Yates et al., 2017). Walking not only lowers blood glucose but provides an outlet to improve
mental health and wellbeing (Reynolds, 2020). Providers must educate on the importance of
walking interventions for type II diabetic patients to improve outcomes.
Conceptual Framework/Model
The Iowa Model of Evidenced-Based Practice was utilized as the conceptual model for
the project related to walking interventions for type II diabetic patients. Triggers identified for
the exercise project were lack of exercise compliance among type II diabetics due to lack of
knowledge, finances, and feelings of being overwhelmed by the thought of exercise (Iowa Model
Collaborative, 2017; Reynolds et al., 2020). Next, the clinical question was established per the
Iowa Model such as, in type II diabetic patients, what is the effect of walking 45 minutes three
times a week on HgbA1c levels compared with no exercise within three months (Iowa Model

WALKING TO IMPROVE OUTCOMES

12

Collaborative, 2017). Based on research, the topic is a priority so the team implemented the
practice change and disseminated results (Iowa Model Collaborative, 2017).
A copy of the Iowa Model of Evidenced-Based Practice is included (Appendix B).
Summary
The literature review revealed type II diabetics are at increased risk of serious
complications due to the disease process and poor glycemic control (Buttaro et al., 2021).
Exercise is a vital component of type II diabetic treatment plans related to lifestyle changes
(Caron et al., 2018; Chang et al., 2020; Moghetti et al., 2020; Regeer et al., 2020; Reynolds et al.,
2020; Ruffino et al, 2017; Yates et al., 2017). Many type II diabetics struggle with exercise
compliance (Reynolds et al, 2020). The simple exercise intervention of walking is effective in
improving glucose control and preventing adverse outcomes (Chang et al., 2021; Cigarroa et al.,
2020; Karstoft et al., 2017; Ruffino et al., 2017). Exercise instructions for walking can increase
exercise compliance. The purpose of this DNP scholarly project is to conduct research outcomes
that may enlighten providers to prescribe exercise interventions by providing evidence that
walking 45 minutes three times a week can improve glycemic control among type II diabetic
patients.
SECTION THREE: METHODOLOGY
Design
The evidenced based DNP scholarly project related to walking interventions to improve
outcomes among type II diabetic patients was conducted by utilizing the Iowa Model for
Evidenced Based Practice. Approval was granted to use the Iowa Model and is located in
Appendix B. The pilot study of the project consists of a quasi-experimental design to evaluate
walking and glycemic control among type II diabetic patients (Sullivan, 2018). A group of type
II diabetic patients were recruited from a primary care office to volunteer to participate in the
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quasi- experimental study. Each participant was instructed to walk 45 minutes three times a week
and log walking activities. The team leader (DNP student), physician, and office staff educated
participants regarding the study, walking requirements, and impacts on disease processes. The
length of the study was 12 weeks and HgbA1c was tested initially and at the end of the 12 weeks.
Participants were required to have a documented HgA1c within six months of beginning the
project.
Measurable Outcomes
Glycated Hemoglobin (HgbA1c)
Setting
The DNP scholarly project was completed at a clinic in Roanoke, Texas which cares for a
large population of uninsured patients with many deficits in social determinants of health. The
clinic serves a significant population of uncontrolled type II diabetic patients who lack the
resources and knowledge to optimally manage their disease. The clinic’s mission is to provide
low-cost healthcare to underserved populations which aligns with the purpose of this project. Dr.
Griffin (owner and primary provider) gave permission to conduct the project within the clinic
and offered to help as needed. Stakeholders included the community, patients, caretakers, Dr.
Griffin, office staff and the DNP student leader. The vision of the project is to provide a low-cost
exercise intervention to type II diabetic patient to improve glucose control and utilize data to
inform future practice. A copy of site letter of support is included in the appendix C.
Population
This low-income type II diabetic population is desperately in need of low-cost lifestyle
interventions to improve glucose control and overall health which was the rational for selecting
this patient population and feasible intervention. Convivence sampling was utilized to obtain five
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participants from the clinic to complete the study. Inclusion criteria included ages 18-80, male or
female, diagnosed with type II diabetes, and ability to walk without assistive devices. Exclusion
criteria includes no hospitalizations within the last six months. Average participants consisted of
uninsured working-class patients ages 43-77 years old.
Ethical Considerations
Training in research ethics has been completed to ensure protection of human subjects
when conducting research. The project was submitted to Liberty University’s institutional review
board (IRB) and complied with ethical research standards for the protection of participants. A
copy of IRB approval is provided in appendix B. A copy of the DNP students Collaborative
Institutional Training Initiative (CITI) Certificate is attached in appendix D. Informed consent
was delivered for all participants including risks and benefits of participating in the walking
study. Participant confidentiality was maintained throughout the project. The researchers
maintained professional conduct and vowed to always protect the rights of all human subjects.
Walking prescriptions were given to participants to improve glucose control and the researchers
pledged to do no harm. Ethical treatment of participants was maintained throughout the entire
project.
Data Collection
The DNP student along with the office staff collected HgbA1c levels at the beginning of
the DNP scholarly project before implementation of walking interventions. If the patient had a
documented HgbA1c within six months, no beginning lab work was required. Then HgbA1c was
collected at 12 weeks which was the end of the intervention period. The team scheduled
participants to come into the clinic for lab work and the DNP student collected all data and
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organized to evaluate. The DNP student collected walking logs at 3, 6, 9 and 12 weeks of the
study and analyzed to evaluate compliance with walking prescriptions.
Tools
Participants logged walking dates and times every week and presented to the DNP project
leader to evaluate compliance at weeks 3, 6, 9, and 12. HgA1c levels were logged on an excel
spread sheet by the DNP student to evaluate and analyze glycemic control related to walking.
Intervention
The team first began with the project development and plan. Next, IRB approval was
secured. Then through convenience sampling the student gained five type II diabetic participants
through the clinic. Clinic staff was educated on the project and trained regarding patient lab
scheduling and patient education. The team educated participants and provided informed consent
for the project. Participants were educated on the importance of lifestyle changes such as
walking to improve glucose control and overall outcomes. Participants were instructed to walk
45 minutes three times a week for 12 weeks. Before implementation the team collected baseline
HgbA1c levels from all participants or allowed previously obtained HgbA1c results within six
months of the project start date. Participants logged times walked each week and presented logs
on weeks 3, 6, 9, and 12. HgbA1c was collected again at the end of the 12 weeks. The
implementation period was completed over 12 weeks and then the team evaluated and analyzed
results. The process was completed over 12 weeks to increase compliance and provide enough
time to improve glycemic control.
Timeline
The timeline for the scholarly project table depicts the milestones accomplished
throughout the project including a description of all stages. (See Table 1.) Each milestone and
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deliverable were accomplished by the dates listed. The DNP scholarly project proceeded in a
systematic process and was completed according to the timeline.
Table 1
Timeline for scholarly project
Milestone

Deliverable

Description

Estimated
Completion
Date

Proposal

Design and Proposal

Project
January 30,
development/plan/proposal 2022

Defense

Proposal defense

Scholarly proposal defense
with chair

January 31,
2022

IRB

Submission

Submit to IRB for
approval

February 1,
2022

IRB

Granted IRB
Approval

IRB approval

February 15,
2022

Sample

DNP student
recruits’ sample

Collect Sample

March 25,
2022

Educate

DNP student
educates

Educate clinic staff

March 28,
2022

Educate

DNP student obtains
informed consent

Educate
participants/informed
Consent

March 29,
2022

Collect

DNP student with
office staff obtains
initial lab work

Initial HgA1c check

March 30,
2022

Start

Intervention

Implementation start date

April 3, 2022

Collect

Exercise progress
update

Exercise log check at 3
weeks

April 23,
2022

Collect

Exercise progress
update

Exercise log check at 6
weeks

May 14,
2022

Collect

Exercise progress
update

Exercise log check at 9
weeks

June 4, 2022
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Collect

Project results

12-week HgbA1c check
and exercise log check

June 27,
2022

Analyze

Completed project

Evaluate and analyze
results – meet with
statistician

June 30,
2022

Final Defense

Final Defense

Defend scholarly project

July 8, 2022

Feasibility Analysis
The cost associated with the project includes HgbA1c level testing. Cost at a local lab
without insurance is $40.00 per patient. Participants paid for HgbA1c testing initially and post
intervention. The clinic allowed the DNP student to conduct the project free of charge. Overall,
the project was considered cost effective as the walking intervention could be completed
anywhere with no associated gym fees.
Data Analysis
A statistician was consulted related to measurable outcomes and statistical analysis.
HgbA1c was evaluated to determine effectiveness of walking interventions for type II diabetic
patients through the quasi-experimental study. Descriptive statistics and inferential statistics
including paired t-testing was utilized to determine statistical significance of the walking
intervention and glucose control (Sullivan, 2018).
Measurable Outcome 1
HgbA1c was tested before and after walking implementations to determine if walking 45
minutes three times a week improved glycemic control by lowering HgbA1c levels. Statistical
significance was inferred if the p value was less than 0.05 and paired t-testing was utilized to
determine if walking improved HgbA1c levels (Sullivan, 2018).
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SECTION FOUR: RESULTS
The study began with five participants. Overall, four patients completed the study with
one drop out. Aggregate demographics of the group consisted of the following: Caucasian,
overweight males, type II diabetics, ages 43-77, working class, and mostly uninsured. The most
successful participant was mostly compliant with walking only missing a few days due to
sickness and his HgbA1c decreased from 10.5 to 6.6. The other four participants HgbA1c levels
on average stayed the same as the initial result mostly likely due to missed walking sessions.
However, the average HgbA1c of the sample decreased from 8.4 to 7.475. (See Table 2.) Three
of the four participants lost weight after completing the study. (See Table 3.) Common causes of
missed walking sessions included sickness, work obligations, and knee pain.
Table 2
Participant HgbA1c levels before and after walking implementation
Pt #

Initial HgbA1c

Post Walking Intervention HgbA1c

Difference

1

7.6

7.7

-0.1

3

10.5

6.6

3.9

4

5.4

5.5

-0.1

5

10.1

10.1

0

Mean

8.4

7.475

0.925

STD

2.376271589

1.967019742

1.983893478
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Table 3
Participant weight tracking
Pt #

Initial weight

Post weight

Difference

(lbs.)

(lbs.)

1

206

204

2

3

258

252

6

4

188

184

4

5

299

305

-6

mean

237.75

236.25

1.5

Descriptive Statistics
Paired t-testing was used to determine statistical significance. Data were evaluated based
on participants initial HgbA1c and then the post intervention HgbA1c. Even though the average
HgbA1c decreased overall the results were not statistically significant. The p value was
0.419860968 which is not considered statistically significant. (See Table 4.)
Measurable Outcome
HgbA1c was the measurable outcome of the study. Overall, the mean of HgbA1c levels
decreased from 8.4 to 7.475. The average difference was 0.925 from starting HgbA1c levels to
post intervention HgbA1c levels.
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Table 4
Paired t-testing statistics for initial and post walking intervention
Initial

Post Walking Intervention

HgbA1c

HgbA1c

Mean

8.4

7.475

Variance

5.646666667

3.869166667

Observations

4

4

Pearson Correlation

0.596897017

Hypothesized Mean Difference

0

df

3

t Stat

0.932509744

P(T<=t) one-tail

0.209930484

t Critical one-tail

2.353363435

P(T<=t) two-tail

0.419860968

t Critical two-tail

3.182446305

SECTION FIVE: DISCUSSION
Implication for Practice
This DNP scholarly project holds clinical and practical significance for type II diabetic
patients. Walking is a practical intervention which is effective for improved glucose control and
overall health. This project is important for medical providers to prescribe specific exercise
interventions instead of simply instructing type II diabetic patients to exercise. Walking is a
simple, low-cost intervention for type II diabetics to apply to lifestyle interventions to improve
glucose control (Chang et al., 2021; Cigarroa et al., 2020; Karstoft et al., 2017; Ruffino et al.,
2017). The project is important to the general public as walking increases overall health,
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wellbeing and can contribute to weight loss (Arovah et al., 2018; Chang et al., 2021; Karstoft et
al., 2017; Moghetti et al., 2020; Regeer et al., 2020). Providers must educate on the importance
of walking for type II diabetic patients to improve health and prevent complications from poor
glucose control (Chang et al., 2021; Moghetti et al., 2020; Ruffino et al, 2017; Yates et al.,
2017). Detailed exercise instructions such as walking in addition to medications and diet is
essential for improved outcomes and prevention of complications among type II diabetic patients
(Caron et al., 2018; Chang et al., 2020; Moghetti et al., 2020; Regeer et al., 2020; Reynolds et al.,
2020; Ruffino et al, 2017; Yates et al., 2017).
Sustainability
Prescribing walking prescriptions for type II diabetic patients is sustainable within
practice to improve glucose control and overall health. A printed handout with walking
instructions to walk 45 minutes three times a week would be beneficial for patients and
providers. Low-cost interventions for type II diabetic patients are important to the community as
most patients are among the uninsured working class. Limitations of the study included a small
sample size and lack of compliance due to weather, motivation, time, employment constraints,
and knee pain. Patient accountability, encouragement, and increased education were important
lessons learned for increased compliance. The project could be more statistically significant with
a larger sample size.
Dissemination Plan
Dissemination of these results were presented to the clinic staff and may potentially be
used to develop new policies within the practice. These results can be the basis for another larger
study related to walking and type II diabetic glucose control.
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Appendix A
Evidence Table

Name: Kelley Leigh Sanders
Clinical Question: In type II diabetic patients, what is the effect of walking 45 minutes three times a week on HgbA1c levels compared with
no exercise within three months?

Article Title, Author, etc. (Current
APA Format)

Study
Purpose

To evaluate the
effectiveness
Washington, T. L., & Heesch, K.
and feasibility
of walking
C. (2018). Walking with diabetes
programs to
improve
(WW-DIAB) programme a
overall health
and glycemic
walking programme for
control for type
Indonesian type 2 diabetes mellitus II diabetic
patients.

Arovah, N. I., Kushartanti, B. M. W.,

patients: A pilot randomized
controlled trial. SAGE Open
Medicine, 6,

Sample
(Characteristic
s of the
Sample:
Demographics,
etc.)
A recruited
sample of 43
type II diabetic
patients from a
public hospital
in Yogyakarta,
Indonesia.

Methods

A
randomized
controlled
trial.

Study
Results

Findings
indicate
walking
improves
glucose levels
and overall
physical
activity in
type II
diabetic
patients.
Walking
programs for
type II
diabetic
patients are
feasible. Also,

Would Use
as Evidence
Level of
Study
to Support a
Evidence
Limitation
Change?
(Use Melnyk
s
(Yes or No)
Framework)
Provide
Rationale.
Level 2:
All
Yes, this
Randomized participants randomized
controlled
were
controlled
trial.
recruited
trial provides
from the
evidence
same
walking can
hospital
improve
and the
glucose
study
control and
included a physical
small
activity for
sample
type II
size.
diabetic
patients.
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205031211881439. https://doi.org/
10.1177/2050312118814391
Caron, N., Peyrot, N., Caderby, T.,
Verkindt, C., & Dalleau, G.
(2018). Effect of type 2 diabetes
on energy cost and preferred speed
of walking. European Journal of
Applied Physiology, 118(11),
23312338. https://doi.org/10.1007/s004
21-018-3959-z

Chang, C., Kuo, C., Huang, C., Hwang, S.,
Liao, W., & Lee, M. (2021).
Habitual physical activity and

text support
increased
walking
compliance.
To compare
A volunteered
A nonFindings
metabolic rate, sample of 20
randomized indicate type
energy cost
type II diabetic controlled
II diabetic
and speed of
patients and 20 trial.
patients walk
walking
healthy patients.
with a higher
effectiveness
metabolic rate
between type II
at all speeds
diabetic
compared to
patients and
healthy adult
healthy
patients. Type
patients.
II diabetic
patients tend
to select
slower speeds
of walking to
compensate
for higher
energy
requirements
which allows
them to gain
an intense
workout even
at slower pace
due to higher
metabolic
demands.
Seeks to
A study sample A
Findings
determine if
of 206 type II
descriptive
indicate
moderate daily diabetic patients correlational glucose
physical
which were
study using control is
activity among recruited from
evaluation
improved
type II diabetic an
via
with moderate
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Level 3:
Controlled
trial with no
randomizatio
n.

Not
randomized
and the
diabetic
sample did
not have
comorbiditi
es such as
peripheral
vascular
disease
which is
very
common
among the
vast
majority of
type II
diabetic
patients.

Yes, this
controlled
study
provided
evidence for
walking
prescriptions
for type II
diabetics
which can be
considered
moderate
intensity
exercise. The
simple
exercise of
walking is an
effective
exercise for
type II
diabetic
patients.

Level 6:
Correlational
descriptive
study.

Sample
was
recruited
using a
convenienc
e sample

Yes, this
study
provides
evidence for
the
effectiveness
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diabetes control in young and
patients
improves
older adults with type II diabetes:
glycemic
control?
A longitudinal correlational

study. International Journal of
Environmental Research and
Public Health, 18(3),

28
endocrinology
outpatient
clinic. 95% of
patients within
the study
experienced
poor glycemic
control. The
mean hgbA1c
was 7.8 %.

questionnair
es.

daily exercise
among type II
diabetic
patients.
HgbA1c
improved
with daily
exercise.
More minutes
of daily
exercise
improves
glycemic
control.

5520 type II
diabetic patients
ages 15 to 90
years old were
recruited from
Chilean
National Health
Survey between
2016 and 2017.
Participants
rated walking
pace as slow,
average, or
brisk.

A nonexperiential
descriptive
survey.

Findings
indicated
participants
who selfreported a
brisk walking
pace had
lower Hgba1c
levels and
better glucose
control.
However,
those with
average and
brisk walking
paces had
lower glucose
levels when
compared to
all
participants.

1330. https://doi.org/10.3390/ijerp
h18031330
Cigarroa, I., Espinoza-Sanhueza, M. J.,
Lasserre-Laso, N., Diaz-Martinez,
X., Garrido-Mendez, A., MatusCastillo, C., Martinez-Sanguinetti,
M. A., Leiva, A. M., PetermannRocha, F., Parra-Soto, S., ConchaCisternas, Y., Troncoso-Pantoja,
C., Martorell, M., Ulloa, N.,
Waddell, H., & Celis-Morales, C.
(2020). Association between
walking pace and diabetes:
Findings from the Chilean national

To assess
walking pace
related to type
II diabetic
glucose control
among type II
diabetics who
walk for
exercise.

Level 6:
Descriptive
study.

which can
limit
generalizab
ility. Also,
the study
utilized
used
subjective
data which
increases
the risk of
recall bias.

of daily
moderate
exercise such
as walking to
improve
glycemic
control
among type
II diabetic
patients.

Multimorbi
dity, body
mass index,
and
socioecono
mic status
may have
impacts on
findings.
Also, selfreporting
could
impact
reliability.

Yes, even
though level
6 evidence
this study
provides
evidence that
average to
brisk walking
can improve
glucose
control and
health among
type II
diabetics.
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health survey 2016–
2017. International Journal of
Environmental Research and
Public Health, 17(15),
5341. https://doi.org/10.3390/ijerp
h17155341

Edmealem, A., Ademe, S., & Tegegne, B.
(2020). Level of physical activity
and its associated factors among

To evaluate
factors related to
physical activity
(exercise)
among type II
diabetic patients.

364 type II
diabetic patients
were selected
through
systematic
random sampling
from a hospital in
Ethiopia.

A crosssectional
observational
study.

Depression,
Level 6:
widowed,
Descriptive
living in urban study.
area, and length
of disease were
associated with
lack of exercise
among type II
diabetic
patients. More
education is
needed for type
II diabetics to
be successful
with physical
activity.

Researchers
noted
potential for
recall bias.

This study can
be used to
stress the
importance of
education
regarding
physical
activity for
type II
diabetics and
how to
overcome
barriers to
exercise.

To assess the
acute effects of
exercise in
adults with type
II diabetes.

PRISMA
guidelines were
utilized for
inclusion of
studies related to

Systematic
review of
randomized
controlled
trials.

Aerobic
exercise
improved
glycemic
control

Level 1:
Systematic
review of
RCTs.

Small
sample size
was a
limitation of
the study.

This study can
be used to aid
in exercise
recommendati
ons for type II

type II diabetes patients in Dessie
referral hospital, northeast
Ethiopia. Diabetes, Metabolic
Syndrome and Obesity, 13, 40674075. https://doi.org/10.2147/DMS
O.S279772

Hicks, D., Hickner, R. C., Govinden, U., &
Sookan, T. (2021). Acute effects
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exercise and type
II diabetes. Three
studies were
included in the
systematic review
out of 205 total
studies.

of single-bout exercise in adults
with type 2 diabetes: A systematic
review of randomized controlled
trials and controlled crossover

compared to
resistance
training. High
intensity
interval
training is
highly effective
for type II
diabetic
patients who
can tolerate.
Aerobic
exercise is
effective in
lowering
glucose within
the first 24
hours after
exercise.

trials. JEMDSA: The Journal of
Endocrinology, Metabolism and
Diabetes of South Africa, 26(1),
2428. https://doi.org/10.1080/160896
77.2020.1850033

Karstoft, K., Clark, M. A., Jakobsen, I.,
Müller, I. A., Pedersen, B. K.,
Solomon, T. P. J., & Reid-Larsen,
M. (2017). The effects of 2 weeks
of interval vs continuous walking
training on glycemic control and
whole-body oxidative stress in
individuals with type 2 diabetes: A
controlled, randomized, crossover

To determine
the impacts of
interval
walking
compared to
continuous
walking on
glycemic
control among
type II diabetic
patients.

14 type II
diabetic
participants
with a BMI >18
were recruited
to participate in
this randomized
controlled trial.

A
randomized
controlled
trial.

Interval
walking
improved
glycemic
control over
continuous
walking
among type II
diabetic
patients with a
BMI >18.

diabetic
patients to
improve
outcomes.

Level 2:
Randomized
controlled
trial

This study
presented
with a
small
sample size
and
interventio
ns only
lasted two
weeks.

Yes, this
study can be
used to aid in
exercise
prescriptions
for type II
diabetic
patients.
Patients who
can tolerate
interval
walking may
have more
improved
glucose
control.
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trial. Diabetologia, 60(3), 508517. https://doi.org/10.1007/s0012
5-016-4170-6
Moghetti, P., Balducci, S., Guidetti, L.,
Mazzuca, P., Rossi, E., Schena, F.,
the Italian Society of Motor and
Sports Sciences (SISMES), the
Italian Society of Diabetology
(SID), the Italian Association of
Medical Diabetologists (AMD),
Italian Society of Motor and
Sports Sciences (SISMES), Italian
Society of Diabetology (SID), &
Italian Association of Medical
Diabetologists (AMD). (2020).
Walking for subjects with type 2
diabetes: A systematic review and
joint AMD/SID/SISMES
evidence-based practical
guideline. Nutrition, Metabolism,

To conduct a
systematic
review related
to walking
interventions
among type II
diabetic
patients to
provide
clinical
recommendatio
ns

28 random
controlled trials
were included
from 1872
screened
randomized
controlled trials.
Inclusion
criteria
maintained all
participants
must be
diagnosed type
II diabetic
patients,
participation in
a structured
walking
program,
random
controlled trials,
and intervention
length of at
least eight
weeks.

A
systematic
review of
RCTs.

Walking
among type II
diabetic
patients
improves
glucose
control, body
weight, blood
pressure and
over all
cardiorespirat
ory fitness.
Interval
walking
exercises are
effective and
can be
prescribed
especially in
younger
patients who
are already
physically fit.

Level 1:
Systematic
review of
RCTs.

Many
patients
with type II
diabetes
have
comorbid
conditions
which need
special care
before
implementi
ng walking
prescriptio
ns.

Yes, this
study can be
utilized in
proving the
necessity of
walking
prescriptions
for type II
diabetic
patients. This
study proved
walking is
the
intervention
of choice for
type II
diabetic
patients to
improve
quality of
life, glucose
control, and
decrease
adverse
effects.
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and Cardiovascular
Diseases, 30(11), 18821898. https://doi.org/10.1016/j.nu
mecd.2020.08.021
Regeer, H., Huisman, S. D., Empelen, P.,
Flim, J., & Bilo, H. J. G. (2020).
Improving physical activity within
diabetes care: Preliminary effects
and feasibility of a national low‐
intensity group‐based walking
intervention among people with
type 2 diabetes mellitus. Lifestyle
Medicine, 1(2),
n/a. https://doi.org/10.1002/lim2.1
0

To assess
feasibility and
effectiveness
of low
intensity
walking
intervention
among patients
with type II
diabetes.

189 type II
diabetic patients
participated in a
20-week group
walking
intervention
study and were
recruited from
15 primary care
practices.

A nonrandomized
controlled
trial.

Low intensity
walking
improved type
II diabetic
patients
HgA1c,
emotional
health and
decreased
somatic
complaints.
Walking
interventions
proved
feasible to
implement.
Group
walking is
especially
effective for
improved
outcomes and
socialization.
Participants
also reported
wanting to eat
healthier after
walking.

Level 3:
Nonrandomized
controlled
trial.

Nonrandomized
design is a
limitation
within the
study.

Yes, this
study proves
walking to be
a feasible
intervention
to improve
glucose
control
among type
II diabetic
patients in
addition to
quality of
life.
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Pamungkas, R. A., Chamroonsawasdi, K.,
& Vatanasomboon, P. (2017). A
systematic review: Family support
integrated with diabetes selfmanagement among uncontrolled
type II diabetes mellitus

To review how
family support
impacts type II
diabetic patients
and selfmanagements
such as diet,
exercise,
medications, and
lifestyle
interventions.
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Through
systematic search
22 studies were
included in this
review using
Joanna Briggs
Institute
guidelines.

A systematic
review.

Family support
improves
adherence to
lifestyle
changes like
diet and
exercise.

Level 1:
Systematic
review of
RCTs.

The
researchers
report
publication
bias due to
tendency to
publish
more
positive than
negative.

This study can
be utilized to
stress the
importance of
involving
family and
support
persons when
instructing on
lifestyle
changes to
improve
outcomes for
type II
diabetics.

28 type II
diabetic adults
were recruited
from general
practices and
outpatient
clinics in
Dunedin, New
Zealand to
complete a
three-month
walking trial to
evaluate
barriers.

Nonrandomized
controlled
trial.

Walking
prescriptions
increased time
of physical
activity and
self-rated
overall health
among type II
diabetic
patients.
Barriers for
walking
included
walking in the
dark during
evenings
causing

Level 3:
Nonrandomized
controlled
trial.

Study was
not
randomized
, involved a
small
sample
size, and
included
selfreporting.

Yes, this
study proves
walking
prescriptions
for type II
diabetic
patients
beneficial in
increasing
walking
adherence
and
improving
overall health
and mental
wellbeing.

patients. Behavioral
Sciences, 7(3),
62. https://doi.org/10.3390/bs7030
062

To determine
barriers
support walking prescriptions for
experienced by
type II diabetic
type 2 diabetes management?
patients who
were
facilitators and barriers following a
prescribed
walking
3-month prescription. Journal of
exercise
prescriptions to
Primary Health Care, 12(2), 173improve
180. https://doi.org/10.1071/HC20 glycemic
control.

Reynolds, A. N. (2020). How do we

023
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Ruffino, J. S., Songsorn, P., Haggett, M.,
Edmonds, D., Robinson, A. M.,
Thompson, D., & Vollaard, N. B.
J. (2017). A comparison of the
health benefits of reduced-exertion
high-intensity interval training
(REHIT) and moderate-intensity

34

To compare
the
effectiveness
of reduced
exertion
interval
training and
moderate
intensity
walking among
type II diabetic
patients.

21 type II
diabetic patients
were recruited
from local UK
advertisements
and Southwest
Primary Care
Research
Network.
Among the
recruited
sample 16
patients
completed the
eight-week
study.

A nonrandomized
controlled
trial

To assess timing
of exercise in
relation to
improved
glucose.

48 participants
were selected
randomly to
participate in the
randomized
controlled trial.

A
randomized
controlled
trial.

walking in type 2 diabetes
patients. Applied Physiology,
Nutrition, and Metabolism, 42(2),
202-

participants to
be scared and
participants
expressing no
desire to
walk.
Both high
intensity
interval
training and
moderate
intensity
walking
interventions
improved
mean arterial
pressure and
plasma
fructosamine.
Reduced
exertion
interval
training
improved
overall fitness
over walking.

Level 3:
Nonrandomized
controlled
trial

The study
was not
randomized
and
included a
small
sample
size. The
safety of
interval
training
among type
II diabetic
patients
needs more
research.

Yes, walking
improves
blood
pressure and
overall health
of type II
diabetic
patients.
Walking
must be a
long-term
intervention
for type II
diabetics. It
is not a short
term
treatment.

Level 1:
Randomized
Controlled
Trial.

Some nondiabetic
patients
were
included in
the study.

This study can
be utilized to
encourage
walking after
breakfast to
improve

208. https://doi.org/10.1139/apnm2016-0497

Solomon, T. P. J., Tarry, E., Hudson, C.
O., Fitt, A. I., & Laye, M. J.
(2020). Immediate post-breakfast

Exercising after
breakfast was
most effective
in lowering
blood glucose.
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glycemic
control.

physical activity improves
interstitial postprandial glycemia:
A comparison of different activitymeal timings. Pflügers
Archiv, 472(2), 271280. https://doi.org/10.1007/s0042
4-019-02300-4

West, A. B., Konopka, A. R., LeBreton, K.
A., Miller, B. F., Hamilton, K. L.,
& Leach, H. J. (2020).
Incorporating behavior change
strategies into an exercise trial to
improve physical activity
maintenance among adults at high
risk for type II diabetes. Journal of
Aging and Physical Activity, 28(6),
813821. https://doi.org/10.1123/JAPA.
2019-0307

To assess
behavior change
strategies among
those high risk
for type II
diabetics
completing an
exercise
program.

50 participants
were recruited for
the study after
completing the
original exercise
trial and were
randomized to
the intervention
or control group

A
randomized
controlled
trial.

Education such
as group
discussions
related to the
benefits of
exercise,
barriers, and
goal setting
improved
exercise
adherence.

Level 1:
Randomized
Controlled
Trial.

Researchers
stressed
future
studies need
more
diverse
participants.

This study can
be utilized to
encourage
group
education to
improve type
II diabetic
exercise
adherence.
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Yates, T., Edwardson, C. L., Henson, J.,
Gray, L. J., Ashra, N. B.,
Troughton, J., Khunti, K., &
Davies, M. J. (2017). Walking
away from type 2 diabetes: A
cluster randomized controlled
trial. Diabetic Medicine, 34(5),
698707. https://doi.org/10.1111/dme.1
3254

To determine if
educational
behavioral
interventions
for walking are
effective in
increasing
walking
activity among
patients at risk
for type II
diabetes.

36
A sample of
808 patients at
high risk for
type II diabetes
were recruited
from ten
primary care
offices in
Leicestershire,
UK.

A
randomized
controlled
trial

The
intervention
group (with
group
education)
increased
walking
behaviors
over the
control group
while
participating
within the
study.

Level 2:
Randomized
controlled
trial

Type II
diabetes
risk was
not
assessed
through
HgbA1c
but through
risk scoring
which is
less
accurate.

Yes, this
study can be
utilized to
provide
evidence for
education
and support
among
patients to
improve
exercise
adherence
and overall
results.
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Letter of Support
To whom it may concern:
I, hereby, grant Kelley L. Sanders permission to conduct a scholarly project related to type II
diabetes and walking within Roanoke Family Medicine in Roanoke, Texas. Kelley may
implement her DNP scholarly project under my supervision.

_______________________
Dr. Brad Griffin, DO

12-9-2020
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Appendix D

CITI Training Certificate

This is to certify that:

Kelley Sanders
Has completed the following CITI Program course:
Biomedical Research - Basic/Refresher
(Curriculum Group)

Biomedical & Health Science Researchers
(Course Learner Group)

1 - Basic Course
(Stage)

Under requirements set by:
Liberty University
Not valid for renewal of certification through CME.

Completion Date Expiration Date Record ID
16-Dec-2021 15-Dec-2024 46373137
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Appendix E

Patient Consent
Title of the Project: WALKING TO IMPROVE OUTCOMES IN PATINET’S WITH TYPE II
DIABETES
Principal Investigator: Kelley Sanders, RN BSN, Liberty University DNP student
Invitation to be Part of a Research Study
– You are invited to participate in a research study. To participate, you must be ages
18-70 years old, male, or female, diagnosed with type II diabetes, and ability to
walk without assistive devices. Taking part in this research project is voluntary.
Please take time to read this entire form and ask questions before deciding whether to take part in
this research.

•

What is the study about and why is it being done?
The purpose of this project is to conduct research outcomes that may enlighten providers
to prescribe exercise interventions by providing evidence, that walking 45 minutes three
times a week can improve glycemic control among type II diabetic patients.

•

Walking is a significant intervention for type II diabetic patients to improve outcomes,
improve quality of life and prevent complications.

•

The project aims to prove walking is an effective and feasible exercise intervention for
type II diabetic patients.

What will happen if you take part in this study?
If you agree to be in this study, I will ask you to do the following things:
• A group of type II diabetics will be selected by the DNP student to participate in walking
45 minutes three times a week for 12 weeks.
• The projected outcome is lowered HgbA1c among participants walking three times a
week.
• HgbA1c will be evaluated at the beginning of the project and at the end of the 12 weeks.
• Participants will document exercise on a provided exercise log and the DNP student will
check frequently in in with participants and provide education as needed.
How could you or others benefit from this study?
The direct benefits participants should expect to receive from taking part in this study are
lowered HgbA1c by walking three times a week for 45 minutes and improved overall health.
What risks might you experience from being in this study?
The risks involved in this study include possible injury from walking and possible hypoglycemia
during walking. The risks involved in this study are minimal, which means they are equal to the
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risks you would encounter in everyday life. The researchers are mandatory reporters and must
report abuse or self-harm.
How will personal information be protected?
The records of this study will be kept private. No names will be published with HgbA1c levels.
Published reports will not include any information that will make it possible to identify a subject.
Research records will be stored securely, and only the researchers will have access to the
records. Data collected from you may be shared for use in future research studies or with other
researchers. If data collected from you is shared, any information that could identify you, if
applicable, will be removed before the data is shared.
•
•
•
•

Participant responses and exercise logs will be anonymous. Participant responses will be
kept confidential using codes. Interviews will be conducted in a location where others
will not easily overhear the conversation.
Data will be stored on a password-locked computer and may be used in future
presentations. After three years, all electronic records will be deleted
Interviews/focus groups will be recorded and transcribed. Recordings will be stored on a
password locked computer for three years and then erased. Only the researchers will have
access to these recordings.
Confidentiality cannot be guaranteed in focus group settings. While discouraged, other
members of the focus group may share what was discussed with persons outside of the
group.

How will you be compensated for being part of the study?
Participants will not be compensated for participating in this study.
What are the costs to you to be part of the study?
To participate in the research, you will need to pay for two HgbA1c laboratory lab tests.
However, if the patient has a documented HgbA1c result within six months the patient will only
need to pay for one HgbA1c lab test at the end of the study.
Is study participation voluntary?
Participation in this study is voluntary. Your decision whether to participate will not affect your
current or future relations with Liberty University or Roanoke Family Medicine. If you decide to
participate, you are free to not answer any question or withdraw at any time without affecting
those relationships.
What should you do if you decide to withdraw from the study?
If you choose to withdraw from the study, please contact the researcher at the email
address/phone number included in the next paragraph. Should you choose to withdraw, data
collected from you will be destroyed immediately and will not be included in this study.
Whom do you contact if you have questions or concerns about the study?
The researcher conducting this study is Kelley Sanders, RN BSN, Liberty University DNP
Student. You may ask any questions you have now. If you have questions later, you are
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. You may also contact the researcher’s faculty

Whom do you contact if you have questions about your rights as a research participant?
If you have any questions or concerns regarding this study and would like to talk to someone
other than the researchers, you are encouraged to contact the Institutional Review Board, 1971
University Blvd., Green Hall Ste. 2845, Lynchburg, VA 24515 or email at irb@liberty.edu.
Disclaimer: The Institutional Review Board (IRB) is tasked with ensuring that human subjects
research will be conducted in an ethical manner as defined and required by federal regulations.
The topics covered and viewpoints expressed or alluded to by student and faculty researchers
are those of the researchers and do not necessarily reflect the official policies or positions of
Liberty University.
Your Consent
By signing this document, you are agreeing to be in this study. Make sure you understand what
the study is about before you sign. You will be given a copy of this document for your records.
The researchers will keep a copy with the study records. If you have any questions about the
study after you sign this document, you can contact the study team using the information
provided above.
I have read and understood the above information. I have asked questions and have received
answers. I consent to participate in the study.
____________________________________
Printed Subject Name
____________________________________
Signature & Date
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Appendix F
Walking log
Weeks of Walking –
45 minutes 3 times a week
WEEK #1

WEEK #2

WEEK #3 (Exercise Check In)

WEEK #4

WEEK #5

WEEK #6 (Exercise Check In)

WEEK #7

Log walking dates and times
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WEEK #8

WEEK #9 (Exercise Check In)

WEEK #10

WEEK #11

WEEK #12 (Exercise Check in & LAB
CHECK)
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Appendix G
Project Budget

~4 Patients
~2 HgbA1c checks each
*40.00 x 2 = 80.00
*80.00 x 4 = $320.00
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Appendix H
IRB Approval Documentation

February 15, 2022
Kelley Sanders
Debra Maddox
Re: IRB Application - IRB-FY21-22-692 WALKING TO IMPROVE OUTCOMES IN
PATINET’S WITH TYPE II DIABETES
Dear Kelley Sanders and Debra Maddox,
The Liberty University Institutional Review Board (IRB) has reviewed your
application in accordance with the Office for Human Research Protections
(OHRP) and Food and Drug Administration (FDA) regulations and finds your
study does not classify as human subjects research. This means you may begin
your project with the data safeguarding methods mentioned in your IRB
application.
Decision: No Human Subjects Research
Explanation: Your study is not considered human subjects research for the
following reason:
Evidence-based practice projects are considered quality improvement activities,
which are not “designed to develop or contribute to generalizable knowledge”
according to 45 CFR 46.102(l).
Please note that this decision only applies to your current application, and any
modifications to your protocol must be reported to the Liberty University IRB for
verification of continued non-human subjects research status. You may report
these changes by completing a modification submission through your Cayuse IRB
account.
Also, although you are welcome to use our recruitment and consent templates,
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you are not required to do so. If you choose to use our documents, please replace
the word research with the word project throughout both documents.
If you have any questions about this determination or need assistance in
determining whether possible modifications to your protocol would change your
application's status, please email us at irb@liberty.edu.
Sincerely,
G. Michele Baker, MA, CIP
Administrative Chair of Institutional Research
Research Ethics Office

